e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Interventional pulmonology and pleural diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
When to use fibrinolytics in empyema- are there clear recommendations?
J. Plutinsky, Z. Taligova, S. Szaboova, I. Libakova, K. Bitter (Nitra, Slovakia)
Source:
Annual Congress 2013 –Interventional pulmonology and pleural diseases
Session:
Interventional pulmonology and pleural diseases
Session type:
Poster Discussion
Number:
3102
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Plutinsky, Z. Taligova, S. Szaboova, I. Libakova, K. Bitter (Nitra, Slovakia). When to use fibrinolytics in empyema- are there clear recommendations?. Eur Respir J 2013; 42: Suppl. 57, 3102
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Efficacy and safety of a new pleural device for the ambulatory management of pneumothorax
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015
Diagnosis and management of pneumothorax: An audit of local prevalence, aetiology and adherence to national guidelines
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013
Is empirical antibiotic treatment correlated to outcome in microbiology-negative pleural infection?
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016
Update on novel anticoagulants: indications, dosing alternatives and outcomes
Source: International Congress 2018 – Pulmonary embolism: what we need to know
Year: 2018
Prescriptions for treatment in patients with PCD: does clinical routine match recommendations?
Source: Virtual Congress 2020 – Worldwide respiratory disease across the full spectrum
Year: 2020
Current practice: Pleural fluid sampling and analysis - how well are we doing?
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Outpatient management of primary spontaneous pneumothorax- A safety and economic review
Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases
Year: 2013
Therapeutic strategies in pneumonia: going beyond antibiotics
Source: Eur Respir Rev 2015; 24: 516-524
Year: 2015
Treatment options and recommendations
Source: Virtual Congress 2021 – ERS guidelines on non-continuous positive airway pressure therapies in obstructive sleep apnoea
Year: 2021
Treatment options and recommendations
Source: International Congress 2019 – European guidelines for malignant pleural mesothelioma management in 2019
Year: 2019
Treatment options and recommendations
Source: Virtual Congress 2021 – ERS clinical practice guidelines on treatment of sarcoidosis
Year: 2021
Treatment options and recommendations
Source: Virtual Congress 2021 – ERS Clinical practice guidelines for managing children and adolescents with bronchiectasis
Year: 2021
Characterising asthma therapy in Scotland: Are the guidelines confusing?
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012
Cleaning agents and asthma: what does the evidence currently tell us about diagnosis and management of these cases?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018
In whom should regular asthma controller therapy be initiated?
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Domiciliary nebuliser treatment: Do we follow the guidelines?
Source: Eur Respir J 2003; 22: Suppl. 45, 147s
Year: 2003
The issues and the controversies: are we really ready for on-demand use of ICS?
Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use?
Year: 2013
Clinical management of COPD: recommended practice including the place of antibiotics
Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Year: 2008
Rational monitoring of COPD: where do current clinical guidelines stand?
Source: Eur Respir J 2007; 29: 1078-1081
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept